Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
Volume: 378, Issue: 13, Pages: 1177 - 1188
Published: Mar 29, 2018
Abstract
Since 2004, a regimen of 6 months of treatment with oxaliplatin plus a fluoropyrimidine has been standard adjuvant therapy in patients with stage III colon cancer. However, since oxaliplatin is associated with cumulative neurotoxicity, a shorter duration of therapy could spare toxic effects and health...
Paper Details
Title
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
Published Date
Mar 29, 2018
Volume
378
Issue
13
Pages
1177 - 1188
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History